Obese Children and Adolescents, Adolescent Obesity, Obesity, Body Mass Index
Conditions
Keywords
Obesity, Body mass index, Virtual Reality games, aerobic exercise, adolescent obesity, obese children, Moderate intensity aerobic exercise, dietary advices
Brief summary
This trial is aiming to study the effect of virtual reality video gaming in comparison with moderate intensity aerobic exercises on lipid profile in children with Obesity
Detailed description
The study will assess whether virtual reality games, dietary advices and moderate intensity aerobic exercise lead to significant differences in lipid profile in class I obese adolescent children. Additionally, the study will examine whether these interventions has impacts on the children body mass index.
Interventions
moderate intensity aerobic exercises (using treadmill training) 5 times per week for 12 weeks. Each participating child started the session with 5 minutes of warming-up exercises. Then the main exercise phase is performed at 50-60% of age-predicted peak heart rate using a treadmill for 30 minutes. Finally, a 5 min cool-down period is allowed, the total session took 40 minutes.
OTHERDietary Advices
The Obese adolescent children participated in the study received diet advices based on a balanced low calorie diet (1500 Kcal)
OTHERVirtual reality games exercise
Virtual reality games exercises 5 times per week for 12 weeks. Each participating child started the session with 5 minutes warming up exercises then followed by the main part which was consisted of 30 min of exercise where the child played the game using virtual reality X-Box and did different physical activities that included both the upper and lower extremities according to the game's requirements, and after that a 5 min cool-down part that involved some static flexibility exercises to allow the heart rate to lower, the total session that would be applied about 40 min (including 30 mins of Virtual reality exercises)
Sponsors
Badr University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
11 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Obese adolescent children * age from 11 to 18 years old only. * Class I Obesity (Body Mass Index from 30 to 34.99 kg/m2) * Clinically and medically stable * Without any impairment of sensation or other neurological or psychological problems.
Exclusion criteria
* Adolescents with visual and/or auditory defects * Normal weight adolescent children (Body Mass Index from 18 to 24.99 kg/m2) or below average weight (BMI less than 18 kg/m2) or Class II and III Obesity (BMI above 35 kg/m2) * Children with significant tightness and/or deformity of upper or lower limbs * Participants with neurological disorders that affect balance or mentality (e.g. epilepsy). * Adolescents with advanced radiographic changes include: Bone destruction, Bony ankylosis, Knee joint subluxation, and Epiphysial fracture) * Any lower limb deformities in the lower limbs. * Participants with cardiopulmonary diseases. * Diabetic children or those under insulin therapy, uncontrolled bronchial asthma, anemia, and Pathological causes of obesity (endocrinal, genetic syndromes...etc.).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Body mass index | From enrollment to the end of treatment at 12 weeks | It is the weight (in kilograms) divided by the height (in meter squares) |
| Serum triglycerides | From enrollment to the end of treatment at 12 weeks | Level of triglycerides fats in blood in measured in laboratory using venous blood sample |
| Total Cholesterol | From enrollment to the end of treatment at 12 weeks | Level of total cholesterol in blood in measured in laboratory using venous blood sample |
| High Density Lipoproteins (HDL) | From enrollment to the end of treatment at 12 weeks | High Density Lipoproteins (HDL) cholesterol fats are measured in laboratory using a venous blood sample |
| Low Density Lipoproteins (LDL) | From enrollment to the end of treatment at 12 weeks | Low Density Lipoproteins (LDL) cholesterol fats are measured in laboratory using a venous blood sample |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| HDL ratio | From enrollment to the end of treatment at 12 weeks | The number of total cholesterol divided by high-density lipoprotein (HDL) |
Countries
Egypt
Outcome results
None listed